These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23724633)

  • 21. Preparation of single donor platelet with low antibody titers for all patients.
    Romphruk AV; Cheunta S; Pakoate L; Kumpeera P; Sripara P; Paupairoj C; Romphruk A
    Transfus Apher Sci; 2012 Apr; 46(2):125-8. PubMed ID: 22365668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current risk for transfusion transmitted infections.
    Dodd RY
    Curr Opin Hematol; 2007 Nov; 14(6):671-6. PubMed ID: 17898573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
    Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
    Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet transfusions: treatment options for hemorrhage secondary to thrombocytopenia.
    Hux BD; Martin LG
    J Vet Emerg Crit Care (San Antonio); 2012 Feb; 22(1):73-80. PubMed ID: 23016744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Quality control of platelet concentrates. Functional assessment of stored platelets in vitro].
    Groh J; Storck K; Kratzer MA
    Anaesthesist; 1993 Dec; 42(12):847-55. PubMed ID: 8304580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. This PUP is not a dog.
    Harrop DE
    Pa Med; 1995 Mar; 98(3):38. PubMed ID: 7724229
    [No Abstract]   [Full Text] [Related]  

  • 27. The cost-effectiveness of reducing donor exposures with single-donor versus pooled random-donor platelets.
    Lopez-Plaza I; Weissfeld J; Triulzi DJ
    Transfusion; 1999 Sep; 39(9):925-32. PubMed ID: 10533816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood safety & prevalence of transfussion transmissible viral infections among donors at the Red Cross Blood Bank in Gondar University Hospital.
    Diro E; Alemu S; G/Yohannes A
    Ethiop Med J; 2008 Jan; 46(1):7-13. PubMed ID: 18711984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of blood transfusion recipients with West Nile virus infections.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Sep; 51(36):823. PubMed ID: 12269472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experience of HLA-matched platelet transfusion in patients who are refractory to random donor platelets].
    Sekiguchi S; Mitani T; Ohnuma M; Katoh T; Ikeda H; Nakase T; Morioka M; Sakurada K; Miyazaki T
    Hokkaido Igaku Zasshi; 1988 Jul; 63(4):552-61. PubMed ID: 3220437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of random versus apheresis platelet concentrates.
    Andreu G; Vasse J; Sandid I; Tardivel R; Semana G
    Transfus Clin Biol; 2007 Dec; 14(6):514-21. PubMed ID: 18417401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet transfusion. Current techniques, remaining problems, and future prospects.
    Herman JH; Kamel HT
    Am J Pediatr Hematol Oncol; 1987; 9(3):272-86. PubMed ID: 3314551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of a European strain of West Nile virus in single- donor platelet concentrate using the INTERCEPT blood system.
    Gallian P; Vignoli C; Dombey AM; Mayaudon V; Lin L; Galichet V; Cantaloube JF; De Micco P
    Vox Sang; 2006 Nov; 91(4):345-7. PubMed ID: 17105611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Scientific background on the risk engendered by reducing the lifetime blood donation deferral period for men who have sex with men.
    Vamvakas EC
    Transfus Med Rev; 2009 Apr; 23(2):85-102. PubMed ID: 19304111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatal group C streptococcal infection due to transfusion of a bacterially contaminated pooled platelet unit despite routine bacterial culture screening.
    Lessa F; Leparc GF; Benson K; Sanderson R; Van Beneden CA; Shewmaker PL; Jensen B; Arduino MJ; Kuehnert MJ
    Transfusion; 2008 Oct; 48(10):2177-83. PubMed ID: 18564393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High concentration plasma-reduced plateletapheresis concentrates.
    Perseghin P
    Transfus Apher Sci; 2011 Jun; 44(3):273-6. PubMed ID: 21507725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period.
    Wendel S; Levi JE; Biagini S; Candotti D; Allain JP
    Transfusion; 2008 Aug; 48(8):1602-8. PubMed ID: 18466175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model.
    Jordan CT; Saakadze N; Newman JL; Lezhava LJ; Maiers TT; Hillyer WM; Roback JD; Hillyer CD
    Transfusion; 2004 Aug; 44(8):1159-65. PubMed ID: 15265119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.